A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants

NCT07671391 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Obesity Adult Onset

Interventions

DRUG: LAE102 +Tirzepatide
DRUG: LAE102 placebo,+Tirzepatide

Sponsor

Shanghai Zhongshan Hospital